Ripple is opening up about its plans to enter one of the world's largest markets.
In new statements to CoinDesk, the San Francisco blockchain startup aimed to address rumors that first appeared last Thursday on XRP Chat, a forum dedicated to gossip and commentary on both the company and its technology.
In short – yes, the blockchain company is planning to set up operations in China, but no, it's not doing so with the help of one of the region's e-commerce giants.
Emi Yoshikawa, Ripple's director of joint venture partnership, told CoinDesk:
Most recently, Ripple added 10 new financial institutions to its blockchain network, including MUFG in Japan, BBVA in Spain and SEB in Sweden, but membership by Chinese firms has so far been absent.
And it appears it will have to keep working on adding a big name from China to that impressive list of collaborators. Ripple also put to rest speculation that Alibaba was already running a validator node on the Ripple network.
Images in the post showed a node that appeared to be operating in Hangzhou, China, with an address linking it to Alibaba Advertising Co., Ltd.
This led some to believe the Chinese mammoth would help Ripple maneuver its way into the country, though a Ripple spokesperson said such an effort is not in the works:
Disclaimer: CoinDesk is a subsidiary of Digital Currency Group, which has an ownership stake in Ripple.
China flag image via Shutterstock
The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups. As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of stock appreciation rights, which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG.